DaVita Inc. (DVA)

Market Cap	12.09B
Revenue (ttm)	12.34B
Net Income (ttm)	815.64M
Shares Out	87.70M
EPS (ttm)	8.80
PE Ratio	15.67
Forward PE	14.42
Dividend	n/a
Ex-Dividend Date	n/a

Volume	456,086
Open	137.59
Previous Close	137.01
Day's Range	136.21 - 138.28
52-Week Range	71.51 - 145.04
Beta	1.04
Analysts	Hold
Price Target	144.33 (+4.68%)
Earnings Date	May 2, 2024

About DVA

DaVita Inc. provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers. In addition...

• Industry: Medical Care Facilities
• Sector: Healthcare
• IPO Date: Oct 31, 1995
• Employees: 70,000
• Stock Exchange: NYSE
• Ticker Symbol: DVA

Financial Performance

In 2023, DaVita's revenue was $12.14 billion, an increase of 4.57% compared to the previous year's $11.61 billion. Earnings were $691.54 million, an increase of 23.40%.

Analyst Forecast

According to 3 analysts, the average rating for DVA stock is "Hold." The 12-month stock price forecast is $144.33, which is an increase of 4.68% from the latest price.

Price Target

$144.33

(4.68% upside)

Analyst Consensus: Hold